Clinical Trial Update: Role of Early API in Accurately Differentiating Hepatocellular Carcinoma From Dysplastic Nodules in Cirrhotic Patients

View source ↗

Summary

This clinical trial update discusses the role of an early API to differentiate hepatocellular carcinoma from dysplastic nodules in patients with cirrhosis. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Dysplastic Nodules
• Hepatocellular Carcinoma

Snippet

Sponsor: Superior University | Conditions: Dysplastic Nodule | Status: ACTIVE_NOT_RECRUITING